An interview to support patients on oral cancer drugs

被引：1

作者：

Thoumas, Xavier Mosnier ^{[1
]}

Mrozovski, Jean-Michel ^{[2
]}

Faure, Sebastien ^{[3
]}

Buxeraud, Jacques ^{[4
]}

机构：

[1] Pharm Corbiac, 73 Route Feydit, F-33160 St Medard En Jalles, France

[2] 26 Rue Terre Neuve, F-92190 Meudon, France

[3] Univ Angers, Fac Sante, Dept Pharm, 16 Blvd Daviers, F-49045 Angers, France

[4] Fac Pharm, 2 Rue Docteur Marcland, F-87025 Limoges, France

来源：

ACTUALITES PHARMACEUTIQUES | 2022年 / 61卷 / 612期

关键词：

adherence; iatrogeny; oral chemotherapy; pharmaceutical maintenance; self-medication;

D O I：

10.1016/j.actpha.2021.12.005

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

An interview to accompany patients on oral anticancer drugs. Each new assignment has its own particularities. The "oral chemotherapy" interview differs from other pharmaceutical interviews by the nature of the drugs it concerns and the specificity of the patients it addresses. It must be very carefully prepared and conducted with rigour by the retail pharmacist. (c) 2021 Elsevier Masson SAS.All rights reserved

引用

页码：18 / 22

页数：5

共 50 条

[21] Adherence to oral anticancer drugs in elderly patients
Choe, M.
Choi, J.
INTERNATIONAL JOURNAL OF NURSING PRACTICE, 2012, 18 : 74 - 74
[22] Oral Antidiabetic Drugs in heart disease Patients
Gallwitz, B.
DIABETOLOGIE UND STOFFWECHSEL, 2016, 11 (02) : R1 - R8
[23] Social support service impact to the anxiety and depression of oral cavity cancer patients in Taiwan
Chueh, Y.
Lin, H.
Yu, C.
Cheng, S.
Chen, I.
Liao, C.
Huang, S.
Chang, J.
EJC SUPPLEMENTS, 2009, 7 (02): : 493 - 493
[24] Experiences of patients with cancer with information and support for psychosocial consequences of reduced ability to eat: a qualitative interview study
Lize, Nora
IJmker-Hemink, Vera
van Lieshout, Rianne
Wijnholds-Roeters, Yvonne
van den Berg, Manon
Soud, Maggy Youssef-El
Beijer, Sandra
Raijmakers, Natasja
SUPPORTIVE CARE IN CANCER, 2021, 29 (11) : 6343 - 6352
[25] Experiences of patients with cancer with information and support for psychosocial consequences of reduced ability to eat: a qualitative interview study
Nora Lize
Vera IJmker-Hemink
Rianne van Lieshout
Yvonne Wijnholds-Roeters
Manon van den Berg
Maggy Youssef-El Soud
Sandra Beijer
Natasja Raijmakers
Supportive Care in Cancer, 2021, 29 : 6343 - 6352
[26] Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs
van Leeuwen, R. W. F.
Brundel, D. H. S.
Neef, C.
van Gelder, T.
Mathijssen, R. H. J.
Burger, D. M.
Jansman, F. G. A.
BRITISH JOURNAL OF CANCER, 2013, 108 (05) : 1071 - 1078
[27] Exploring the factors influencing adherence to oral anticancer drugs in patients with digestive cancer: a qualitative study
Nizet, Pierre
Touchefeu, Yann
Pecout, Solange
Cauchin, Estelle
Beaudouin, Eva
Mayol, Severine
Fronteau, Clementine
Huon, Jean-Francois
SUPPORTIVE CARE IN CANCER, 2022, 30 (03) : 2591 - 2604
[28] Cancer patients' medication knowledge: what about oral immunomodulatory drugs to treat multiple myeloma?
Perichou, Juliette
Ranchon, Florence
Carpentier, Isabelle
Schwiertz, Verane
Vantard, Nicolas
Gourc-Berthod, Chloe
Gauthier, Noemie
Guedat, Marie-Gabrielle
He, Sophie
Kiouris, Elena
Alloux, Celine
Caffin, Anne-Gaelle
Bernard, Delphine
Karlin, Lionel
Salles, Gilles
Rioufol, Catherine
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 199 - 199
[29] Effects of oral 5-fluorouracil drugs on hepatic fact content in patients with colon cancer
Miyake, K
Hayakawa, K
Nishino, M
Morimoto, T
Mukaihara, S
ACADEMIC RADIOLOGY, 2005, 12 (06) : 722 - 727
[30] Quantity and economic value of unused oral cancer drugs among patients who discontinue their therapy
Bekker, C.
Gardarsdottir, H.
Melis, E. J.
Egberts, A. C.
Bouvy, M. L.
van den Bemt, B. J.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (03) : 732 - 732

← 1 2 3 4 5 →